Abstract
The PROMÉTHÉE II multi-criteria decision analysis (MCDA) method performs a preference index as a step of its implementation to express a preference level that an alternative can exert over another one, according to their performances on a set of criteria. This study aims to use the PROMÉTHÉE II’s preference index in order to support the incremental cost-utility ratio (ICUR) analysis between psoriatic arthritis treatments.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
